Proteomic identification of AP2 gamma as a rat placental lactogen II trophoblast cell-specific enhancer binding protein.
The factors that regulate the developmental expression of the rodent prolactin gene family in placenta remain poorly defined. We previously identified an enhancer element in the 5' flanking region of one family member, rat placental lactogen II (rPLII), which could target reporter gene expression to the placenta in transgenic mice; this enhancer functioned in the Rcho rat trophoblast cell line but not in the rat pituitary GC cell line. In further experiments to identify the factors that bind this element, we have selectively enriched for DNA binding proteins in nuclear extract from Rcho cells using magnetic beads coupled to a 43-bp enhancer oligonucleotide. Tryptic peptides of bound proteins were analyzed by HPLC coupled off-line to matrix-assisted laser desorption ionization time of flight mass spectrometry. Several peptides of AP2 gamma, a key trophoblast cell-specific transcription factor, were identified. Gel mobility shift assays using AP2 gamma-specific antiserum and mutant enhancer oligonucleotides demonstrated binding specifically to the FP2 DNase I-protected region of the element, identifying an atypical binding site for this factor. In cotransfection assays in rat pituitary GC cells, AP2 gamma transactivated the enhancer via this region. Chromatin immunoprecipitation assays confirmed AP2 gamma occupancy of the enhancer region in situ in the nuclei of Rcho giant cells. These data support a role for AP2 gamma in the placental giant cell-specific expression of the rPLII gene and provide the first direct evidence for the involvement of a placental-specific transcription factor in the regulation of a member of this gene family.
Oztürk
Arzu
A
Departments of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada R3E 3J7.
Donald
Lynda J
LJ
Li
Lin
L
Duckworth
Harry W
HW
Duckworth
Mary Lynn
ML
D000818:Animals; D001483:Base Sequence; D001665:Binding Sites; D002460:Cell Line; D004247:DNA / Q000378:metabolism; D024202:Electrophoretic Mobility Shift Assay; D004742:Enhancer Elements, Genetic / Q000235:genetics*; D005260:Female; D015870:Gene Expression; D006657:Histones / Q000032:analysis; D006801:Humans; D007163:Immunosorbent Techniques; D008156:Luciferases / Q000235:genetics; D010446:Peptide Fragments / Q000032:analysis / Q000378:metabolism; D010902:Pituitary Gland / Q000378:metabolism; D010928:Placental Lactogen / Q000235:genetics*; D000071137:Poly (ADP-Ribose) Polymerase-1; D011065:Poly(ADP-ribose) Polymerases / Q000032:analysis; D011247:Pregnancy; D040901:Proteomics; D051381:Rats; D011993:Recombinant Fusion Proteins; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D050656:Transcription Factor AP-2 / Q000032:analysis / Q000235:genetics / Q000502:physiology*; D015533:Transcriptional Activation; D014162:Transfection; D014327:Trophoblasts / Q000378:metabolism*; D014357:Trypsin / Q000378:metabolism
D006657:Histones; D010446:Peptide Fragments; D011993:Recombinant Fusion Proteins; D050656:Transcription Factor AP-2; C062303:placental lactogen II; D004247:DNA; D010928:Placental Lactogen; D008156:Luciferases; C499322:Parp1 protein, rat; D000071137:Poly (ADP-Ribose) Polymerase-1; D011065:Poly(ADP-ribose) Polymerases; D014357:Trypsin